Cigna Healthcare, the health benefits division of the Cigna Group, has released a set of digital tools aimed at improving the ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Hims also sells liraglutide, a generic version of an older Novo diabetes drug that also causes weight loss, as well as ...

Hims also sells liraglutide, a generic version of an older Novo diabetes drug that also causes weight loss, as well as branded Wegovy and Eli Lilly's (LLY) rival Zepbound. But analysts question ...

Hims said it is now selling "personalized" dosages of Wegovy ... CVS Health and Cigna announced new strategies for weight-loss drugs, by limiting which it will cover or out-of-pocket costs. Leerink's ...

Currently, three GLP-1 drugs are approved by the Food and Drug Administration for weight management: Saxenda and Wegovy, both manufactured by Danish drugmaker Novo Nordisk; and Zepbound ...

Currently, three GLP-1 drugs are approved by the Food and Drug Administration for weight management: Saxenda and Wegovy, both manufactured by Danish drugmaker Novo Nordisk; and Zepbound ... Novo and ...

These companies, like the rest of the insurance sector, have reported overwhelming utilization of $1,000-per-month medications including Wegovy, Zepbound and Saxenda ... National players UnitedHealth ...